Robin Joan Steele has an estimated net worth of $13.4 Million. This is based on reported shares across multiple companies, which include Dare Bioscience, Inc., INTERMUNE INC, and Targanta Therapeutics Corp..
2011 was Robin Joan Steele's most active year for acquiring shares with 18 total transactions. Robin Joan Steele's most active month to acquire stocks was the month of April. 2011 was Robin Joan Steele's most active year for disposing of shares, totalling 26 transactions. Robin Joan Steele's most active month to dispose stocks was the month of April. 2011 saw Robin Joan Steele paying a total of $4,521,377.41 for 382,338 shares, this is the most they've acquired in one year. In 2011 Robin Joan Steele cashed out on 786,155 shares for a total of $16,212,953.12, their largest year based on trade value.